The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

View/ Open
Citation
World Health Organization. (2016). The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. World Health Organization. http://www.who.int/iris/handle/10665/250614
Description
58 p.ISBN
9789241549899Collections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Target regimen profiles for TB treatment: candidates: rifampicin-susceptible, rifampicinresistant and pan-TB treatment regimens
World Health Organization (WHO/HTM/TB/2016.16, 2016) -
The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis / Bjorn Blomberg ... [et al.]
Blomberg, Bjorn; Spinaci, Sergio; Fourie, Bernard; Laing, Richard (2001) -
WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis
World Health Organization (WHO/CDS/TB/2018.7, 2018)